Natural Product: NPC329277

Natural Product ID:  NPC329277
Common Name:   Diquafosol
IUPAC Name:   [[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [[[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl] hydrogen phosphate
Synonyms:   Diquafosol; INS-365
Molecular Formula:   C18H26N4O23P4
Standard InCHIKey:  NMLMACJWHPHKGR-NCOIDOBVSA-N
Standard InCHI:  InChI=1S/C18H26N4O23P4/c23-9-1-3-21(17(29)19-9)15-13(27)11(25)7(41-15)5-39-46(31,32)43-48(35,36)45-49(37,38)44-47(33,34)40-6-8-12(26)14(28)16(42-8)22-4-2-10(24)20-18(22)30/h1-4,7-8,11-16,25-28H,5-6H2,(H,31,32)(H,33,34)(H,35,36)(H,37,38)(H,19,23,29)(H,20,24,30)/t7-,8-,11-,12-,13-,14-,15-,16-/m1/s1
Canonical SMILES:  O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(OP(=O)(OC[C@H]2O[C@H]([C@@H]([C@@H]2O)O)n2ccc(nc2=O)O)O)O)O)O)O[C@H]([C@@H]1O)n1ccc(nc1=O)O
First Find Year:  
Max Developmental Stage:  
Synthetic Gene Cluster:   ;

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO20338 Mus musculus Species Muridae Eukaryota PMID[19425150]

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT3826 Individual Protein Purinergic receptor P2Y2 Homo sapiens EC50 = 210 nM 17302398
NPT3827 Individual Protein Pyrimidinergic receptor P2Y4 Homo sapiens EC50 = 130 nM 17302398
NPT1391 Individual Protein Pyrimidinergic receptor P2Y6 Homo sapiens EC50 = 20000 nM 17302398
NPT3825 Individual Protein Purinergic receptor P2Y1 Homo sapiens EC50 > 20000 nM 17011188
NPT3826 Individual Protein Purinergic receptor P2Y2 Homo sapiens EC50 = 210 nM 18514530
NPT3827 Individual Protein Pyrimidinergic receptor P2Y4 Homo sapiens EC50 = 130 nM 18514530
NPT1391 Individual Protein Pyrimidinergic receptor P2Y6 Homo sapiens EC50 = 1160 nM 18514530
NPT3826 Individual Protein Purinergic receptor P2Y2 Homo sapiens EC50 = 112 nM 19419204
NPT3826 Individual Protein Purinergic receptor P2Y2 Homo sapiens EC50 = 270000 nM 19419204
NPT3826 Individual Protein Purinergic receptor P2Y2 Homo sapiens EC50 = 179 nM 19419204
NPT3826 Individual Protein Purinergic receptor P2Y2 Homo sapiens EC50 = 94.5 nM 19419204
NPT3826 Individual Protein Purinergic receptor P2Y2 Homo sapiens EC50 = 394 nM 19419204
NPT3826 Individual Protein Purinergic receptor P2Y2 Homo sapiens EC50 = 572 nM 19419204
NPT3826 Individual Protein Purinergic receptor P2Y2 Homo sapiens EC50 = 419 nM 19419204
NPT3826 Individual Protein Purinergic receptor P2Y2 Homo sapiens EC50 = 620000 nM 19419204
NPT3826 Individual Protein Purinergic receptor P2Y2 Homo sapiens EC50 = 145 nM 19419204
NPT3826 Individual Protein Purinergic receptor P2Y2 Homo sapiens EC50 = 216 nM 19419204
NPT3826 Individual Protein Purinergic receptor P2Y2 Homo sapiens EC50 = 231 nM 19419204
NPT3826 Individual Protein Purinergic receptor P2Y2 Homo sapiens EC50 > 300000 nM 19419204
NPT3826 Individual Protein Purinergic receptor P2Y2 Homo sapiens Ratio EC50 = 25 19419204
NPT3826 Individual Protein Purinergic receptor P2Y2 Homo sapiens EC50 = 100 nM 20095577
NPT3826 Individual Protein Purinergic receptor P2Y2 Homo sapiens EC50 = 60 nM 22107038

  Similar Natural Products in NPASS

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC329277 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.8969 High Similarity NPC73765
0.8969 High Similarity NPC283698
0.8866 High Similarity NPC36985
0.8866 High Similarity NPC17892
0.866 High Similarity NPC320249
0.866 High Similarity NPC322594
0.8557 High Similarity NPC324390
0.8491 Intermediate Similarity NPC149843
0.8491 Intermediate Similarity NPC155087
0.8218 Intermediate Similarity NPC317639
0.8144 Intermediate Similarity NPC89051
0.8144 Intermediate Similarity NPC43246
0.7941 Intermediate Similarity NPC318166
0.7941 Intermediate Similarity NPC324516
0.7835 Intermediate Similarity NPC106780
0.7745 Intermediate Similarity NPC327344
0.757 Intermediate Similarity NPC328914
0.7549 Intermediate Similarity NPC315063
0.7547 Intermediate Similarity NPC328779
0.7453 Intermediate Similarity NPC120887
0.7438 Intermediate Similarity NPC284651
0.7358 Intermediate Similarity NPC280946
0.7358 Intermediate Similarity NPC226769
0.7358 Intermediate Similarity NPC6166
0.7353 Intermediate Similarity NPC163352
0.7353 Intermediate Similarity NPC210456
0.729 Intermediate Similarity NPC90240
0.7264 Intermediate Similarity NPC329384
0.7157 Intermediate Similarity NPC325723
0.7059 Intermediate Similarity NPC112842
0.7059 Intermediate Similarity NPC71339
0.6887 Remote Similarity NPC171116
0.6869 Remote Similarity NPC329077
0.6698 Remote Similarity NPC62927
0.6698 Remote Similarity NPC190334
0.6693 Remote Similarity NPC315058
0.6538 Remote Similarity NPC313962
0.6471 Remote Similarity NPC325902
0.6415 Remote Similarity NPC229249
0.6222 Remote Similarity NPC318142
0.6036 Remote Similarity NPC328806
0.6031 Remote Similarity NPC325750
0.6 Remote Similarity NPC478024
0.5926 Remote Similarity NPC319753
0.5922 Remote Similarity NPC315806
0.5841 Remote Similarity NPC109188
0.5736 Remote Similarity NPC313813
0.5686 Remote Similarity NPC316244

  Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC329277 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
1.0 High Similarity NPD3129 Phase 3
0.9897 High Similarity NPD3128 Phase 3
0.9151 High Similarity NPD3139 Phase 3
0.9057 High Similarity NPD3138 Phase 3
0.8969 High Similarity NPD9639 Clinical (unspecified phase)
0.8144 Intermediate Similarity NPD9580 Clinical (unspecified phase)
0.8144 Intermediate Similarity NPD9581 Clinical (unspecified phase)
0.7677 Intermediate Similarity NPD9557 Clinical (unspecified phase)
0.7642 Intermediate Similarity NPD5789 Clinical (unspecified phase)
0.757 Intermediate Similarity NPD1455 Phase 3
0.757 Intermediate Similarity NPD1454 Phase 3
0.75 Intermediate Similarity NPD1686 Approved
0.7476 Intermediate Similarity NPD9565 Discontinued
0.7273 Intermediate Similarity NPD9556 Approved
0.7241 Intermediate Similarity NPD7914 Suspended
0.7212 Intermediate Similarity NPD755 Phase 3
0.72 Intermediate Similarity NPD9561 Approved
0.72 Intermediate Similarity NPD9560 Approved
0.7184 Intermediate Similarity NPD241 Discontinued
0.7129 Intermediate Similarity NPD9546 Phase 2
0.71 Intermediate Similarity NPD9558 Phase 3
0.708 Intermediate Similarity NPD6946 Approved
0.7064 Intermediate Similarity NPD502 Approved
0.7059 Intermediate Similarity NPD280 Approved
0.7059 Intermediate Similarity NPD9533 Phase 2
0.7054 Intermediate Similarity NPD1061 Clinical (unspecified phase)
0.6923 Remote Similarity NPD240 Phase 3
0.6923 Remote Similarity NPD170 Approved
0.6923 Remote Similarity NPD9562 Discovery
0.6917 Remote Similarity NPD7761 Suspended
0.6887 Remote Similarity NPD841 Approved
0.6818 Remote Similarity NPD762 Discontinued
0.6796 Remote Similarity NPD9559 Phase 1
0.6796 Remote Similarity NPD9529 Phase 1
0.6789 Remote Similarity NPD501 Phase 1
0.6759 Remote Similarity NPD251 Approved
0.6759 Remote Similarity NPD6943 Clinical (unspecified phase)
0.6731 Remote Similarity NPD238 Clinical (unspecified phase)
0.6731 Remote Similarity NPD239 Phase 2
0.6698 Remote Similarity NPD9602 Phase 3
0.6698 Remote Similarity NPD9604 Approved
0.6698 Remote Similarity NPD9603 Phase 3
0.6667 Remote Similarity NPD7756 Clinical (unspecified phase)
0.6637 Remote Similarity NPD223 Clinical (unspecified phase)
0.6606 Remote Similarity NPD9585 Discontinued
0.6542 Remote Similarity NPD1760 Approved
0.6522 Remote Similarity NPD7651 Approved
0.6452 Remote Similarity NPD7992 Clinical (unspecified phase)
0.6441 Remote Similarity NPD1385 Discontinued
0.6415 Remote Similarity NPD9601 Approved
0.6228 Remote Similarity NPD514 Clinical (unspecified phase)
0.6182 Remote Similarity NPD9553 Approved
0.6182 Remote Similarity NPD301 Discontinued
0.6182 Remote Similarity NPD9554 Approved
0.6148 Remote Similarity NPD284 Phase 1
0.6134 Remote Similarity NPD4743 Phase 2
0.6132 Remote Similarity NPD9600 Approved
0.6106 Remote Similarity NPD279 Clinical (unspecified phase)
0.6071 Remote Similarity NPD267 Discontinued
0.6053 Remote Similarity NPD215 Discontinued
0.6019 Remote Similarity NPD9572 Clinical (unspecified phase)
0.6 Remote Similarity NPD6948 Phase 3
0.6 Remote Similarity NPD2633 Phase 1
0.5983 Remote Similarity NPD192 Phase 2
0.5968 Remote Similarity NPD1804 Phase 2
0.5968 Remote Similarity NPD1805 Phase 2
0.5935 Remote Similarity NPD6693 Phase 3
0.5929 Remote Similarity NPD500 Discontinued
0.5926 Remote Similarity NPD2691 Clinical (unspecified phase)
0.5926 Remote Similarity NPD9573 Phase 2
0.5922 Remote Similarity NPD9653 Clinical (unspecified phase)
0.5902 Remote Similarity NPD1428 Phase 2
0.5888 Remote Similarity NPD9429 Discontinued
0.5841 Remote Similarity NPD1331 Approved
0.581 Remote Similarity NPD9407 Approved
0.5766 Remote Similarity NPD9555 Phase 2
0.5714 Remote Similarity NPD3121 Phase 2
0.5692 Remote Similarity NPD6936 Clinical (unspecified phase)
0.5692 Remote Similarity NPD6935 Phase 3
0.5657 Remote Similarity NPD9504 Approved
0.5657 Remote Similarity NPD9503 Approved
0.5648 Remote Similarity NPD9427 Approved

Structure

External Identifiers

PubChem CID   148197
ChEMBL   CHEMBL221326
ZINC  

Physicochemical Properties

Molecular Weight:  789.99
ALogP:  -5.2592
MLogP:  0.03
XLogP:  -8.32
# Rotatable Bonds:  24
Polar Surface Area:  439.77
# H-Bond Aceptor:  27
# H-Bond Donor:  10
# Rings:  4
# Heavy Atoms:  49

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs